Stock VRDN VIRIDIAN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Viridian Therapeutics, Inc.

Equities

VRDN

US92790C1045

Real-time Estimate Cboe BZX
Other stock markets
 03:02:22 2024-05-23 pm EDT 		5-day change 1st Jan Change
11.9 USD -6.30% Intraday chart for Viridian Therapeutics, Inc. -19.00% -45.59%
May. 16 Transcript : Viridian Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 04:35 PM
May. 09 Oppenheimer Adjusts Viridian Therapeutics Price Target to $31 From $36, Maintains Outperform Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. VRDN Stock
  4. Revisions Viridian Therapeutics, Inc.